Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-02-28 @ 10:52 PM
Study NCT ID:
NCT06585969
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-10-10
First Post:
2024-08-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer
Sponsor:
Danish Breast Cancer Cooperative Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DBCG-R25-DISCORDANT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None